BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-918@pharmaconomics
DTSTAMP:20260707T033835Z
DTSTART;VALUE=DATE:20260217
DTEND;VALUE=DATE:20260218
SUMMARY:NRXP AdCom — NRX-100
DESCRIPTION:An FDA advisory committee reviews NRX-100 for ketamine around Feb 17\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1719406/000143774926004246/nrxp20260216c_8k.htm\n\nTrack it: https://pharmaconomics.com/e/918
URL:https://pharmaconomics.com/e/918
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:NRXP catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR